Opioid drugs are widely used as analgesics but cause respiratory depression, a potentially lethal side-effect with overdose, by acting on µ-opioid receptors (MORs) expressed in brainstem regions involved in the control of breathing. Although many brainstem regions have been shown to regulate opioid-induced respiratory depression, the types of neurons involved have not been identified. Somatostatin is a major neuropeptide found in brainstem circuits regulating breathing, but it is unknown whether somatostatin-expressing circuits regulate respiratory depression by opioids. We examined the co-expression ofSst(gene encoding somatostatin) andOprm1(gene encoding MORs) mRNAs in brainstem regions involved in respiratory depression. Interestingly,Oprm1mRNA expression was found in the majority (> 50%) ofSst-expressing cells in the preBötzinger Complex, the nucleus tractus solitarius, the nucleus ambiguus, and the Kölliker-Fuse nucleus. We then compared respiratory responses to fentanyl between wild-type andOprm1full knockout mice and found that the lack of MORs prevented respiratory rate depression from occurring. Next, using transgenic knockout mice lacking functional MORs specifically inSst-expressing cells, we compared respiratory responses to fentanyl between control and the conditional knockout mice. We found that respiratory rate depression by fentanyl was preserved when MORs were deleted only inSst-expressing cells. Our results show that despite co-expression ofSstandOprm1in respiratory circuits and the importance of somatostatin-expressing cells in the regulation of breathing, these cells do not mediate opioid-induced respiratory rate depression. Instead, MORs found in respiratory cell populations other thanSst-expressing cells likely contribute to the respiratory effects of fentanyl.Significance statementOpioid drugs cause respiratory depression, a potentially lethal side-effect with overdose, by acting on µ-opioid receptors in brainstem regions regulating breathing, therefore limiting their effective use as analgesics. Somatostatin is a major neuropeptide found within these brainstem circuits, but it is unknown whether somatostatin circuits regulate respiratory depression by opioids. We found that somatostatin-expressing neurons co-express µ-opioid receptors in respiratory circuits but that respiratory rate depression by fentanyl was preserved despite genetic deletion of µ-opioid receptors in somatostatin-expressing cells. Our results suggest that somatostatin-expressing cells are resistant to the rate-depressive effects of opioids and that other cells contribute to the effects of fentanyl on breathing. Somatostatin-expressing cells may constitute a cell population that can be targeted to stimulate breathing when it fails with opioids.